AlphaCore Capital LLC Purchases Shares of 347 Axon Enterprise, Inc $AXON

AlphaCore Capital LLC acquired a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the second quarter, according to the company in its most recent filing with the SEC. The firm acquired 347 shares of the biotechnology company’s stock, valued at approximately $287,000.

A number of other hedge funds have also recently modified their holdings of AXON. Hemington Wealth Management raised its position in Axon Enterprise by 70.8% during the second quarter. Hemington Wealth Management now owns 41 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 17 shares in the last quarter. Whipplewood Advisors LLC grew its stake in shares of Axon Enterprise by 192.9% during the 2nd quarter. Whipplewood Advisors LLC now owns 41 shares of the biotechnology company’s stock worth $34,000 after purchasing an additional 27 shares during the period. NewSquare Capital LLC increased its holdings in shares of Axon Enterprise by 96.2% during the 2nd quarter. NewSquare Capital LLC now owns 51 shares of the biotechnology company’s stock valued at $42,000 after purchasing an additional 25 shares in the last quarter. Washington Trust Advisors Inc. increased its holdings in shares of Axon Enterprise by 44.7% during the 2nd quarter. Washington Trust Advisors Inc. now owns 55 shares of the biotechnology company’s stock valued at $46,000 after purchasing an additional 17 shares in the last quarter. Finally, TCTC Holdings LLC lifted its stake in shares of Axon Enterprise by 75.0% in the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company’s stock valued at $29,000 after purchasing an additional 24 shares during the period. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts recently commented on the stock. The Goldman Sachs Group dropped their price target on shares of Axon Enterprise from $940.00 to $800.00 and set a “buy” rating on the stock in a research report on Wednesday, November 5th. Bank of America increased their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research note on Wednesday, August 6th. Craig Hallum upgraded Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target for the company in a research note on Tuesday, August 5th. Northland Securities set a $800.00 price target on Axon Enterprise in a report on Tuesday, August 5th. Finally, Zacks Research lowered Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Axon Enterprise currently has an average rating of “Moderate Buy” and an average price target of $814.00.

Insider Activity

In other Axon Enterprise news, CFO Brittany Bagley sold 5,000 shares of Axon Enterprise stock in a transaction on Monday, September 29th. The stock was sold at an average price of $713.88, for a total value of $3,569,400.00. Following the sale, the chief financial officer owned 93,592 shares in the company, valued at $66,813,456.96. The trade was a 5.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jeri Williams sold 100 shares of the company’s stock in a transaction dated Thursday, September 11th. The shares were sold at an average price of $752.54, for a total transaction of $75,254.00. Following the completion of the transaction, the director directly owned 1,416 shares in the company, valued at $1,065,596.64. The trade was a 6.60% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 38,622 shares of company stock worth $26,439,364. 4.40% of the stock is owned by insiders.

Axon Enterprise Stock Up 0.5%

Shares of AXON opened at $524.60 on Tuesday. The stock has a 50 day moving average price of $676.60 and a 200 day moving average price of $731.73. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The stock has a market capitalization of $41.40 billion, a price-to-earnings ratio of 129.53, a PEG ratio of 29.49 and a beta of 1.45. Axon Enterprise, Inc has a one year low of $469.24 and a one year high of $885.91.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Wednesday, November 5th. The biotechnology company reported $1.17 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.46). The business had revenue of $710.64 million for the quarter, compared to analysts’ expectations of $704.83 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.Axon Enterprise’s quarterly revenue was up 30.6% compared to the same quarter last year. During the same period in the previous year, the company earned $1.45 EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.